BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24733050)

  • 21. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
    Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
    Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Nonribosomal Peptide Synthase Gene Driving Virulence in Mycobacterium tuberculosis.
    Bhatt K; Machado H; Osório NS; Sousa J; Cardoso F; Magalhães C; Chen B; Chen M; Kim J; Singh A; Ferreira CM; Castro AG; Torrado E; Jacobs WR; Bhatt A; Saraiva M
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extremely lethal and hypervirulent
    Vinogradova T; Dogonadze M; Zabolotnykh N; Badleeva M; Yarusova I; Vyazovaya A; Gerasimova A; Zhdanova S; Vitovskaya M; Solovieva N; Pasechnik O; Ogarkov O; Mokrousov I
    Emerg Microbes Infect; 2021 Dec; 10(1):1691-1701. PubMed ID: 34380361
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative genomic analysis of peruvian strains of Mycobacterium tuberculosis].
    Tarazona D; Galarza M; Levano KS; Guio H
    Rev Peru Med Exp Salud Publica; 2016 Jun; 33(2):256-63. PubMed ID: 27656924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.
    Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK
    Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.
    Chihota VN; Müller B; Mlambo CK; Pillay M; Tait M; Streicher EM; Marais E; van der Spuy GD; Hanekom M; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; van Helden PD; Warren RM
    J Clin Microbiol; 2012 Mar; 50(3):995-1002. PubMed ID: 22170931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
    Moodley P; Shah NS; Tayob N; Connolly C; Zetola N; Gandhi N; Friedland G; Sturm AW
    PLoS One; 2011; 6(5):e17513. PubMed ID: 21655324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
    Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
    Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium tuberculosis genotypes and predominant clones among the multidrug-resistant isolates in Spain 1998-2005.
    Samper S; Gavín P; Millán-Lou MI; Iglesias MJ; Jiménez MS; ; Couvin D; Rastogi N
    Infect Genet Evol; 2017 Nov; 55():117-126. PubMed ID: 28789982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Diversity of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in the Capital of Iran, Revealed by Whole-Genome Sequencing.
    Vaziri F; Kohl TA; Ghajavand H; Kargarpour Kamakoli M; Merker M; Hadifar S; Khanipour S; Fateh A; Masoumi M; Siadat SD; Niemann S
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30404943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
    Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
    Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.
    Ioerger TR; Koo S; No EG; Chen X; Larsen MH; Jacobs WR; Pillay M; Sturm AW; Sacchettini JC
    PLoS One; 2009 Nov; 4(11):e7778. PubMed ID: 19890396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.